John Phair1, Frank Palella. 1. Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. j-phair@northwestern.edu
Abstract
PURPOSE OF REVIEW: Highly active antiretroviral therapy (HAART) has resulted in a marked decrease in AIDS-related conditions and death. With improved survival, cardiovascular disease, hepatic, renal disease, and non-AIDS-related cancers represent an increasing burden for HIV-infected individuals. RECENT FINDINGS: HIV-associated nephropathy (HIVAN), acute renal injury, HAART, and comorbid conditions such as hepatitis C, hypertension, and diabetes are among the multiple causes of renal disease. In HIVAN there is incomplete understanding of the interaction of the virus with renal cells and the host genetics leading to susceptibility to this form of renal dysfunction. There is agreement that a baseline estimated glomerular filtration should be obtained and that renal function should be monitored during antiretroviral therapy. There is, however, no agreement as to the most accurate method of estimating GFR. Renal transplantation has emerged as a feasible and successful modality of management of end-stage renal disease (ESRD) in HIV-infected individuals. SUMMARY: Kidney disease represents an increasing concern in the care of HIV-infected persons, although there are questions remaining regarding the pathophysiology of HIVAN. Transplantation, however, can be carried out safely in infected persons with ESRD.
PURPOSE OF REVIEW: Highly active antiretroviral therapy (HAART) has resulted in a marked decrease in AIDS-related conditions and death. With improved survival, cardiovascular disease, hepatic, renal disease, and non-AIDS-related cancers represent an increasing burden for HIV-infected individuals. RECENT FINDINGS: HIV-associated nephropathy (HIVAN), acute renal injury, HAART, and comorbid conditions such as hepatitis C, hypertension, and diabetes are among the multiple causes of renal disease. In HIVAN there is incomplete understanding of the interaction of the virus with renal cells and the host genetics leading to susceptibility to this form of renal dysfunction. There is agreement that a baseline estimated glomerular filtration should be obtained and that renal function should be monitored during antiretroviral therapy. There is, however, no agreement as to the most accurate method of estimating GFR. Renal transplantation has emerged as a feasible and successful modality of management of end-stage renal disease (ESRD) in HIV-infected individuals. SUMMARY:Kidney disease represents an increasing concern in the care of HIV-infectedpersons, although there are questions remaining regarding the pathophysiology of HIVAN. Transplantation, however, can be carried out safely in infected persons with ESRD.
Authors: Marcello Tonelli; Paul Muntner; Anita Lloyd; Braden J Manns; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Brenda R Hemmelgarn Journal: Ann Intern Med Date: 2011-01-04 Impact factor: 25.391
Authors: Peter G Stock; Burc Barin; Barbara Murphy; Douglas Hanto; Jorge M Diego; Jimmy Light; Charles Davis; Emily Blumberg; David Simon; Aruna Subramanian; J Michael Millis; G Marshall Lyon; Kenneth Brayman; Doug Slakey; Ron Shapiro; Joseph Melancon; Jeffrey M Jacobson; Valentina Stosor; Jean L Olson; Donald M Stablein; Michelle E Roland Journal: N Engl J Med Date: 2010-11-18 Impact factor: 91.245
Authors: Elizabeth George; Gregory M Lucas; Girish N Nadkarni; Derek M Fine; Richard Moore; Mohamed G Atta Journal: AIDS Date: 2010-01-28 Impact factor: 4.177
Authors: Pablo Labarga; Pablo Barreiro; Luz Martin-Carbonero; Sonia Rodriguez-Novoa; Carmen Solera; Jose Medrano; Pablo Rivas; Marta Albalater; Francisco Blanco; Victoria Moreno; Eugenia Vispo; Vincent Soriano Journal: AIDS Date: 2009-03-27 Impact factor: 4.177
Authors: Rebecca Scherzer; Michelle Estrella; Yongmei Li; Andy I Choi; Steven G Deeks; Carl Grunfeld; Michael G Shlipak Journal: AIDS Date: 2012-04-24 Impact factor: 4.177
Authors: Jose M Miro; Federico Cofan; Joan C Trullas; Christian Manzardo; Carlos Cervera; Montserrat Tuset; Federico Oppenheimer; Mercedes Brunet; Asuncion Moreno; Josep M Campistol; Jose M Gatell Journal: Curr HIV/AIDS Rep Date: 2012-09 Impact factor: 5.071
Authors: François Barbier; Antoine Roux; Emmanuel Canet; Patricia Martel-Samb; Philippe Aegerter; Michel Wolff; Bertrand Guidet; Elie Azoulay Journal: Intensive Care Med Date: 2014-09-19 Impact factor: 17.440
Authors: Kaku A So-Armah; Joyce Chang; Charles Alcorn; Vincent Lo Re; Jason V Baker; Russell Tracy; Adeel A Butt; Brian K Agan; David Rimland; Cynthia L Gibert; Matthew B Goetz; Krisann K Oursler; Maria C Rodriguez-Barradas; Lewis H Kuller; Sheldon T Brown; James H Stein; Melissa Skanderson; Amy C Justice; Matthew S Freiberg Journal: Curr HIV Res Date: 2014 Impact factor: 1.581
Authors: Kaku A Armah; Chung-Chou H Chang; Jason V Baker; Vasan S Ramachandran; Matthew J Budoff; Heidi M Crane; Cynthia L Gibert; Matthew B Goetz; David A Leaf; Kathleen A McGinnis; Krisann K Oursler; David Rimland; Maria C Rodriguez-Barradas; Jason J Sico; Alberta L Warner; Priscilla Y Hsue; Lewis H Kuller; Amy C Justice; Matthew S Freiberg Journal: Clin Infect Dis Date: 2013-09-24 Impact factor: 9.079
Authors: Sang Hoon Han; Seung Up Kim; Chang Oh Kim; Su Jin Jeong; Jun Yong Park; Jun Yong Choi; Do Young Kim; Sang Hoon Ahn; Young Goo Song; Kwang-Hyub Han; June Myung Kim Journal: PLoS One Date: 2013-01-03 Impact factor: 3.240